Comparative 12-month retention rate, effectiveness and tolerability of perampanel when used as a first add-on or a late add-on treatment in patients with focal epilepsies: The COM-PER study

Publication date: Available online 5 February 2021Source: SeizureAuthor(s): Nuno Canas, Catarina Félix, Vanessa Silva, Ana Arraiolos, Fernando Fernandez-Llimos
Source: Seizure - Category: Neurology Source Type: research
More News: Neurology | Study